Prediction of visual field progression in glaucoma

被引:66
作者
Nouri-Mahdavi, K
Hoffman, D
Gaasterland, D
Caprioli, J [1 ]
机构
[1] Univ Calif Los Angeles, Jules Stein Eye Inst, Glaucoma Div, Los Angeles, CA 90095 USA
[2] Univ Ophthalmol Consultants Washington, Washington, DC USA
关键词
D O I
10.1167/iovs.04-0204
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To determine the probability of future glaucomatous visual field (VF) progression with clinical and perimetric data. Methods. One hundred sixty-one eyes of patients (161) enrolled in the Advanced Glaucoma Intervention Study (AGIS) with greater than or equal to8 years of follow-up and a baseline VF score less than or equal to16 were selected. VF progression at 8 years was determined with point-wise linear regression (PLR) analysis, using a two-omitting algorithm. The course of VF series over the first 4 years of follow-up was quantified by an index, the sum of slopes, which is the sum of all slopes of VF thresholds with P<0.05 when PLR was performed on the 4-year data. The following parameters were included in a logistic regression model to predict 8-year outcomes from the first 4 years of follow-up: intervention sequence, age, AGIS VF score, mean IOP, IOP fluctuation, and sum of slopes. Results. Sixty-four (40%) eyes progressed after 8 years as determined by PLR analysis. Two parameters were predictive of subsequent VF progression, as identified at 8 years ( predictive power: 76%): more negative sum of slopes (i.e., faster or more extensive deterioration; P<0.001) and older age at 4 years (P=0.049). When sum of slopes alone was used to predict outcomes at 8 years, the predictive power was the same. Conclusions. The VF sum of slopes can be used to estimate the probability of subsequent VF worsening with reasonable, clinically useful accuracy. This probability may be combined with other clinical information for more effective clinical predictions and treatment decisions.
引用
收藏
页码:4346 / 4351
页数:6
相关论文
共 14 条
[1]  
Blackwell B, 2002, AM J OPHTHALMOL, V134, P499
[2]  
BROWN RH, 1994, CONTROL CLIN TRIALS, V15, P299
[3]  
GAASTERLAND DE, 1994, OPHTHALMOLOGY, V101, P1445
[4]  
Gardiner SK, 2002, INVEST OPHTH VIS SCI, V43, P1400
[5]  
HOLMIN C, 1982, ACTA OPHTHALMOL, V60, P267
[6]  
KRAKAU CET, 1985, ACTA OPHTHALMOL, V63, P19
[7]   MODELING SERIES OF VISUAL-FIELDS TO DETECT PROGRESSION IN NORMAL-TENSION GLAUCOMA [J].
MCNAUGHT, AI ;
CRABB, DP ;
FITZKE, FW ;
HITCHINGS, RA .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1995, 233 (12) :750-755
[8]   Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation [J].
Membrey, WL ;
Poinoosawmy, DP ;
Bunce, C ;
Fitzke, FW ;
Hitchings, RA .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (10) :1154-1158
[9]   Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression [J].
Membrey, WL ;
Bunce, C ;
Poinoosawmy, DP ;
Fitzke, FW ;
Hitchings, RA .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (06) :696-701
[10]   REGRESSION-ANALYSIS OF VISUAL-FIELD PROGRESSION IN LOW TENSION GLAUCOMA [J].
NOUREDDIN, BN ;
POINOOSAWMY, D ;
FIETZKE, FW ;
HITCHINGS, RA .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1991, 75 (08) :493-495